AVR 0.00% $18.00 anteris technologies ltd

world congress of cardiology 2014 melbourne , page-20

  1. 3,092 Posts.
    lightbulb Created with Sketch. 69
    I've said it before although I think it's important that this stays central in peoples' minds….

    People who benefit/win from using a CardioCel patch, patients/patients families/surgeons/hospitals/insurers/governments/tax payers

    People who don't benefit/lose are competitors selling archaic patches not treated with the ADAPT technology.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.